BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jon P Stonehouse. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jon P Stonehouse har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:BCRX / BioCryst Pharmaceuticals, Inc. President & CEO, Director 30.000
US:BLCM / Bellicum Pharmaceuticals, Inc. Director 204.086
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jon P Stonehouse. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb BCRX / BioCryst Pharmaceuticals, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BCRX / BioCryst Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-05-13 BCRX Stonehouse Jon P 30.000 5,5500 30.000 5,5500 166.500 357 11.0300 164.400 98,74
2019-11-18 BCRX Stonehouse Jon P 50.000 1,4500 50.000 1,4500 72.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Insidersalg BCRX / BioCryst Pharmaceuticals, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BCRX / BioCryst Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2012-03-02 BCRX Stonehouse Jon P 2.721 4,7800 2.721 4,7800 13.006 364 1.19 -9.768 -75,10

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

BCRX / BioCryst Pharmaceuticals, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jon P Stonehouse som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-12-23 2024-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 10.000 30.000 50,00
2024-12-23 2024-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 10.000 30.000 50,00
2024-12-23 2024-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift -20.000 1.429.109 -1,38
2024-12-23 2024-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -14.010 1.449.109 -0,96 7,39 -103.534 10.708.916
2024-12-23 2024-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 362.100 1.463.119 32,89
2024-12-17 2024-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -27.525 1.101.019 -2,44 7,53 -207.263 8.290.673
2024-05-15 2024-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
P - Purchase 30.000 1.127.770 2,73 5,55 166.500 6.259.124
2024-01-04 2024-01-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 10.000 20.000 100,00
2024-01-04 2024-01-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 10.000 20.000 100,00
2024-01-04 2024-01-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift -20.000 1.094.770 -1,79
2023-12-20 2023-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -14.089 1.114.770 -1,25 6,05 -85.238 6.744.358
2023-12-18 2023-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -13.592 1.128.859 -1,19 6,43 -87.397 7.258.563
2023-12-18 2023-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 127.500 1.142.451 12,56
2023-06-15 2023-06-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift -25.000 1.014.794 -2,40
2023-03-23 2023-03-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 31.055 1.039.794 3,08 3,22 99.997 3.348.137
2023-02-02 2023-02-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -100.000 1.008.739 -9,02 10,38 -1.038.000 10.470.711
2023-02-02 2023-02-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 100.000 1.108.739 9,91 5,45 545.000 6.042.628
2023-02-02 2022-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 5.000 10.000 100,00
2023-02-02 2022-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 5.000 10.000 100,00
2023-02-02 2022-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift -10.000 1.008.739 -0,98
2023-01-05 2023-01-03 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 121.452 204.086 146,98
2023-01-04 2022-09-01 4/A BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 60.580 82.634 274,69
2022-12-21 2022-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 127.500 1.015.230 14,36
2022-12-19 2022-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -14.100 887.730 -1,56 10,90 -153.690 9.676.257
2022-12-02 2022-12-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -82.656 901.830 -8,40 12,80 -1.057.997 11.543.424
2022-12-02 2022-12-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 82.656 984.486 9,17 1,42 117.372 1.397.970
2022-12-02 2022-12-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -214.917 901.830 -19,24 13,00 -2.793.921 11.723.790
2022-12-02 2022-12-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 214.917 1.116.747 23,83 1,42 305.182 1.585.781
2022-09-02 2022-09-01 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 60.580 103.688 140,53
2022-09-01 2022-01-04 4/A BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 21.054 22.054 2.105,40
2022-01-13 2022-01-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -184.000 0 -100,00
2022-01-13 2022-01-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -184.000 901.602 -16,95 15,04 -2.767.360 13.560.094
2022-01-13 2022-01-11 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 184.000 1.085.602 20,41 4,73 870.320 5.134.897
2022-01-06 2022-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
M - Exercise -21.504 0 -100,00
2022-01-06 2022-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
M - Exercise 21.504 22.504 2.150,40
2021-12-16 2021-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 574.500 574.500
2021-12-16 2021-12-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 123.000 901.602 15,80
2021-12-16 2021-09-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 5.000 5.000
2021-12-16 2021-09-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift 5.000 5.000
2021-12-16 2021-09-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift -5.000 778.602 -0,64
2021-12-16 2021-09-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
G - Gift -5.000 778.602 -0,64
2021-07-07 2021-06-15 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 6.500 6.500
2021-01-05 2021-01-04 4 BLCM BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
A - Award 21.054 21.054
2020-12-17 2020-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 870.000 870.000
2020-12-17 2020-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -134.278 1 -100,00
2020-12-17 2020-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -134.278 784.086 -14,62 8,32 -1.117.193 6.523.596
2020-12-17 2020-12-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 134.278 918.364 17,13 4,15 557.254 3.811.211
2020-12-07 2020-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 157.250 157.250
2020-12-07 2020-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 25.000 25.000
2020-06-16 2020-06-15 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 6.500 6.500
2020-05-15 2020-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 157.250 157.250
2020-02-25 2020-02-21 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 27.140 27.140
2020-02-19 2020-02-14 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 47.495 47.495
2019-12-19 2019-12-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 314.500 314.500
2019-11-18 2019-11-18 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
P - Purchase 50.000 778.086 6,87 1,45 72.500 1.128.225
2019-06-14 2019-06-13 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 25.000 25.000
2019-01-03 2019-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -3.568 724.106 -0,49 8,07 -28.794 5.843.535
2018-12-21 2018-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 675.000 675.000
2018-12-06 2018-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -80.000 0 -100,00
2018-12-06 2018-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -80.000 727.674 -9,90 9,12 -729.600 6.636.387
2018-12-06 2018-12-03 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 80.000 807.674 10,99 1,20 96.000 969.209
2018-11-13 2018-11-09 4 BLCM BELLICUM PHARMACEUTICALS, INC
Common Stock
P - Purchase 10.000 10.000 4,56 45.600 45.600
2018-06-18 2018-06-14 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2018-05-21 2018-05-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -70.427 297.573 -19,14
2018-05-21 2018-05-17 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 70.427 725.519 10,75 1,42 100.006 1.030.237
2018-03-02 2018-02-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -56.949 0 -100,00
2018-03-02 2018-02-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -43.224 655.092 -6,19 4,97 -214.823 3.255.807
2018-03-02 2018-02-28 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 56.949 698.316 8,88 3,26 185.654 2.276.510
2018-01-23 2018-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -9.584 638.367 -1,48 5,59 -53.575 3.568.472
2018-01-03 2018-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2.716 647.951 -0,42 4,91 -13.336 3.181.439
2017-12-22 2017-12-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 300.000 300.000
2017-09-05 2017-08-31 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 40.710 40.710
2017-06-15 2017-06-14 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2017-03-01 2017-02-27 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 500.000 500.000
2017-01-24 2017-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -10.572 645.418 -1,61 5,95 -62.903 3.840.237
2017-01-03 2017-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8.595 655.990 -1,29 6,33 -54.406 4.152.417
2016-06-17 2016-06-15 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2016-05-25 2016-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 337.050 337.050
2016-03-03 2016-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -2.761 664.585 -0,41 2,13 -5.881 1.415.566
2016-01-22 2016-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -10.624 665.702 -1,57 7,55 -80.211 5.026.050
2016-01-21 2016-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -24.096 134.279 -15,21
2016-01-21 2016-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 24.096 676.326 3,69 4,15 99.998 2.806.753
2016-01-05 2016-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8.091 652.230 -1,23 10,32 -83.499 6.731.014
2015-12-31 2015-12-29 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 162.950 162.950
2015-07-17 2015-07-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -33.868 416.132 -7,53
2015-07-17 2015-07-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -25.526 659.211 -3,73 15,67 -399.992 10.329.836
2015-07-17 2015-07-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 33.868 684.737 5,20 11,81 399.981 8.086.744
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise X -20.000 80.000 -20,00
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 650.869 -2,98 15,02 -300.400 9.776.052
2015-06-22 2015-06-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise X 20.000 670.869 3,07 1,20 24.000 805.043
2015-06-19 2015-06-17 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 10.000 10.000
2015-06-16 2015-05-13 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 25.000 25.000
2015-03-03 2015-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -5.118 650.869 -0,78 10,20 -52.204 6.638.864
2015-01-22 2015-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -10.608 654.280 -1,60 11,17 -118.491 7.308.308
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -5.652 664.888 -0,84 12,16 -68.728 8.085.038
2015-01-05 2015-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 28.400 670.540 4,42
2014-12-23 2014-12-19 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 25.000 25.000
2014-12-19 2014-12-17 4 BLCM BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
A - Award 23.529 23.529
2014-05-28 2014-05-26 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 25.000 25.000
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -9.625 158.375 -5,73
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -26.991 116.809 -18,77
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -3.801 56.949 -6,26
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -5.188 640.445 -0,80 7,70 -39.948 4.931.426
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 9.625 645.633 1,51 4,15 39.944 2.679.377
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -23.416 636.008 -3,55 7,70 -180.303 4.897.262
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 26.991 659.424 4,27 6,68 180.300 4.404.952
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -1.610 632.433 -0,25 7,70 -12.397 4.869.734
2014-05-12 2014-05-09 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 3.801 634.043 0,60 3,26 12.391 2.066.980
2014-03-07 2014-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -5.118 630.242 -0,81 11,69 -59.829 7.367.529
2014-02-04 2014-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 84.000 84.000
2014-02-04 2014-01-20 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 128.000 632.360 25,38
2014-01-03 2014-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -8.592 504.360 -1,68 7,60 -65.299 3.833.136
2013-05-28 2013-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
M - Exercise -179.600 100.000 -64,23
2013-05-28 2013-05-23 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
M - Exercise 179.600 509.952 54,37 1,20 215.520 611.942
2013-04-12 2013-01-01 4/A BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 31.300 333.319 10,36
2013-04-12 2013-01-01 4/A BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 31.300 302.019 11,56
2013-03-14 2013-01-31 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 3.000 340.225 0,89 1,38 4.140 469.510
2013-03-06 2013-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -5.967 331.258 -1,77 1,19 -7.101 394.197
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 184.000 184.000
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 184.000 184.000
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 33.253 337.225 10,94
2013-01-07 2013-01-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 33.253 337.225 10,94
2012-03-19 2012-03-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
F - Taxes -13.612 267.719 -4,84 5,23 -71.191 1.400.170
2012-03-19 2012-03-15 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 41.947 281.331 17,52
2012-03-05 2012-03-02 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
S - Sale -2.721 239.384 -1,12 4,78 -13.006 1.144.256
2012-03-05 2012-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Emp. Stock Option (Right to Buy)
A - Award 184.000 184.000 4,73 870.320 870.320
2012-03-05 2012-03-01 4 BCRX BIOCRYST PHARMACEUTICALS INC
Common Stock
A - Award 33.253 242.105 15,92
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)